Key result
Mutations in the ryanodine receptor type 1 (RyR1) associated with malignant hyperthermia enhance sensitivity to caffeine and halothane in skeletal muscle.
RyR1 mutations associated with malignant hyperthermia alter skeletal excitation-contraction coupling by enhancing sensitivity to caffeine and halothane.
Answers are grounded in this paper and cite their sources.
Some MHRyR1 mutations increase caffeine/halothane sensitivity in expression systems; leaves open clinical translation for MH diagnostics.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2003) studied Malignant hyperthermia. RyR1 mutations was evaluated. Mutations in the ryanodine receptor type 1 (RyR1) associated with malignant hyperthermia enhance sensitivity to caffeine and halothane in skeletal muscle.
Synapse has enriched 10 related papers. Consider them for comparative context: